Figure 6From: Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study Immunohistochemistry. Eosinphil granulocytes (panel A) and CD3 positive lymphocytes (panel B), expressed as percentage of lamina propria cells, were quantified in UC and CD. Baseline and final values after 4 months of supplementary lactulose treatment (L) versus standard medication (controls, C) alone are shown.Back to article page